Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
F-star Therapeutics, Inc. | TREASURER AND CHIEF FINANCIAL OFFICER | Common Stock | 0 | $7.12 | Mar 8, 2023 | Direct | |
F-star Therapeutics, Inc. | TREASURER AND CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | 0 | Mar 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FSTX | F-star Therapeutics, Inc. | Mar 8, 2023 | 6 | -$402K | 4 | Mar 9, 2023 | TREASURER AND CHIEF FINANCIAL OFFICER |
FSTX | F-star Therapeutics, Inc. | Mar 31, 2022 | 1 | $0 | 4 | Apr 4, 2022 | Treasurer and CFO |
FSTX | F-star Therapeutics, Inc. | Jan 9, 2022 | 1 | $0 | 4 | Jan 11, 2022 | Treasurer and CFO |
FSTX | F-star Therapeutics, Inc. | Nov 20, 2020 | 1 | $0 | 4/A | Aug 24, 2021 | Treasurer and CFO |